Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Pulmonary Circulation
|
August 16, 2023
Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
Steve Jacobs, Carmen Payne, Sara Shaboodien, et al.
Pulmonary Circulation
|
June 10, 2017
The Pulmonary Vascular Research Institute celebrates its first decade
Jason X-J Yuan, Nicholas W Morrell, Kurt R Stenmark, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 8, 2009
Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis
Alexi Crosby, Frances M Jones, Mark Southwood, et al.
Global Cardiology Science & Practice
|
November 5, 2020
Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
Majdy Idrees, Ghazwan Butrous, Ana Mocumbi, et al.
Pulmonary Circulation
|
April 20, 2026
Schistosomiasis-Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition-2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives
Camila M C Loureiro, Ricardo A Correa, Roberto José de Carvalho Filho, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2011
Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis
Alexi Crosby, Frances M Jones, Ewa Kolosionek, et al.
Circulation
|
September 13, 2003
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease
Ingram Schulze-Neick, Paulina Hartenstein, Jia Li, et al.
Infectious Disease Reports
|
March 24, 2025
COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease
Peter S Nyasulu, Jacques L Tamuzi, Rudolf K F Oliveira, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 10, 2008
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai, Soni Savai Pullamsetti, Eva Dony, et al.
Respiratory Medicine
|
July 24, 2007
Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide
Norbert Weissmann, Boris Gerigk, Ozlem Kocer, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Pulmonary Circulation
|
August 16, 2023
Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
Steve Jacobs, Carmen Payne, Sara Shaboodien, et al.
Pulmonary Circulation
|
June 10, 2017
The Pulmonary Vascular Research Institute celebrates its first decade
Jason X-J Yuan, Nicholas W Morrell, Kurt R Stenmark, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 8, 2009
Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis
Alexi Crosby, Frances M Jones, Mark Southwood, et al.
Global Cardiology Science & Practice
|
November 5, 2020
Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
Majdy Idrees, Ghazwan Butrous, Ana Mocumbi, et al.
Pulmonary Circulation
|
April 20, 2026
Schistosomiasis-Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition-2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives
Camila M C Loureiro, Ricardo A Correa, Roberto José de Carvalho Filho, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2011
Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis
Alexi Crosby, Frances M Jones, Ewa Kolosionek, et al.
Circulation
|
September 13, 2003
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease
Ingram Schulze-Neick, Paulina Hartenstein, Jia Li, et al.
Infectious Disease Reports
|
March 24, 2025
COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease
Peter S Nyasulu, Jacques L Tamuzi, Rudolf K F Oliveira, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 10, 2008
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai, Soni Savai Pullamsetti, Eva Dony, et al.
Respiratory Medicine
|
July 24, 2007
Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide
Norbert Weissmann, Boris Gerigk, Ozlem Kocer, et al.
Page
of 7